LMCB - MRC Laboratory for Molecular Cell Biology


Publication in Cardiology Research for Kriston-Vizi and Ketteler

A new study by Kalkhoran et al, published in Cardiology Research, shows hydralazine, a drug used to treat patients with hypertension and chronic heart failure, can reduce heart attack size and heart muscle cell death by inhibiting mitochondrial fission. 

Reviewed in Nature Reviews Cardiology 

Figure caption: Segmented mitochondria fragments after processing of a 63x fluorescence image, acquired with Opera high-content screening system.